标题
Targeting DNA Methyltranferases in Urological Tumors
作者
关键词
-
出版物
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-04-13
DOI
10.3389/fphar.2018.00366
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Epigenetics and immunotherapy: The current state of play
- (2017) Jennifer Dunn et al. MOLECULAR IMMUNOLOGY
- Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer
- (2017) Swathi Ramakrishnan et al. Cell Death & Disease
- Prospective changes in global DNA methylation and cancer incidence and mortality
- (2016) Brian T Joyce et al. BRITISH JOURNAL OF CANCER
- DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas
- (2016) G. G. Malouf et al. CLINICAL CANCER RESEARCH
- Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
- (2016) Christophe Massard et al. JOURNAL OF CLINICAL ONCOLOGY
- Renal cancer
- (2016) Umberto Capitanio et al. LANCET
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Epigenetic Modulators and the New Immunotherapies
- (2016) Anthony E. Dear NEW ENGLAND JOURNAL OF MEDICINE
- Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells
- (2016) Sarandeep S.S. Boyanapalli et al. PHARMACOLOGICAL RESEARCH
- The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2
- (2016) Dzjemma Sarkisjan et al. PLoS One
- Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer
- (2016) Jaeseob Lee et al. PROSTATE
- Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
- (2016) I. Duran et al. Targeted Oncology
- Epigenetic Determinants of Cancer
- (2016) Stephen B. Baylin et al. Cold Spring Harbor Perspectives in Biology
- Epigallocatechin-3-gallate inhibits migration and invasion of human renal carcinoma cells by downregulating matrix metalloproteinase-2 and matrix metalloproteinase-9
- (2016) SHAO-JUN CHEN et al. Experimental and Therapeutic Medicine
- MGMT and CALCA promoter methylation are associated with poor prognosis in testicular germ cell tumor patients
- (2016) Camila Maria da Silva Martinelli et al. Oncotarget
- Selective DNA methylation in cancers controls collateral damage induced by large structural variations
- (2016) Vakul Mohanty et al. Oncotarget
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- Epigenetic modulators as therapeutic targets in prostate cancer
- (2016) Inês Graça et al. Clinical Epigenetics
- Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies
- (2016) Enrico Munari et al. PLoS One
- Inhibition of DNA Methylation Suppresses Intestinal Tumor Organoids by Inducing an Anti-Viral Response
- (2016) Yoshimasa Saito et al. Scientific Reports
- Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes
- (2016) Stefan Winter et al. Scientific Reports
- Natural compounds: Role in reversal of epigenetic changes
- (2015) Ruchi Aggarwal et al. BIOCHEMISTRY-MOSCOW
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts
- (2015) David Roulois et al. CELL
- Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
- (2015) Katherine B. Chiappinelli et al. CELL
- Phase I/II Study of Azacitidine, Docetaxel, and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Therapy
- (2015) Rakesh Singal et al. Clinical Genitourinary Cancer
- Immunomodulatory action of the DNA methyltransferase inhibitor SGI-110 in epithelial ovarian cancer cells and xenografts
- (2015) Pragya Srivastava et al. Epigenetics
- Epigenetic biomarkers in the blood of patients with urological malignancies
- (2015) Jörg Ellinger et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Role of DNA methylation in renal cell carcinoma
- (2015) Niraj Shenoy et al. Journal of Hematology & Oncology
- Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation
- (2015) Abeer M. Mahmoud et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
- (2015) Jean-Pierre J Issa et al. LANCET ONCOLOGY
- Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re-expressing the epigenetically repressed tumor suppressor-estrogen receptor β
- (2015) Vikas Sharma et al. MOLECULAR CARCINOGENESIS
- Guarding the frontiers: the biology of type III interferons
- (2015) Andreas Wack et al. NATURE IMMUNOLOGY
- 5-Azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene
- (2015) XIAORONG WANG et al. ONCOLOGY REPORTS
- Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target
- (2015) Qianling Liu et al. Oncotarget
- Pharmacological DNA demethylation: Implications for cancer immunotherapy
- (2015) David Roulois et al. OncoImmunology
- Anti-neoplastic properties of hydralazine in prostate cancer
- (2015) Inês Graça et al. Oncotarget
- Development and classes of epigenetic drugs for cancer
- (2014) Dashyant Dhanak et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Aza-deoxycytidine induces apoptosis or differentiation via DNMT3B and targets embryonal carcinoma cells but not their differentiated derivatives
- (2014) P Wongtrakoongate et al. BRITISH JOURNAL OF CANCER
- Active and Passive Demethylation of Male and Female Pronuclear DNA in the Mammalian Zygote
- (2014) Fan Guo et al. Cell Stem Cell
- Anti-Tumoral Effect of the Non-Nucleoside DNMT Inhibitor RG108 in Human Prostate Cancer Cells
- (2014) Ines Graca et al. CURRENT PHARMACEUTICAL DESIGN
- The Epigenetically Regulated Effects of Wnt Antagonists on the Expression of Genes in the Apoptosis Pathway in Human Bladder Cancer Cell Line (T24)
- (2014) Nuray Varol et al. DNA AND CELL BIOLOGY
- Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1
- (2014) Preethi Devanand et al. FEBS Journal
- Natural compounds in epigenetics: A current view
- (2014) Marco Miceli et al. FOOD AND CHEMICAL TOXICOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors
- (2014) Christina Gros et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting DNA Methylation with Small Molecules: What’s Next?
- (2014) Alexandre Erdmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells
- (2014) Sergio Valente et al. JOURNAL OF MEDICINAL CHEMISTRY
- Testicular Cancer — Discoveries and Updates
- (2014) Nasser H. Hanna et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
- (2014) Ilaria Naldi et al. PLoS One
- An Epigenetic Screen Unmasks Metallothioneins as Putative Contributors to Renal Cell Carcinogenesis
- (2014) Imad Alkamal et al. UROLOGIA INTERNATIONALIS
- Promoter hypermethylation of tumor suppressor genes correlates with tumor grade and invasiveness in patients with urothelial bladder cancer
- (2014) Shumaila M Bilgrami et al. SpringerPlus
- Identification of Novel Inhibitors of DNA Methylation by Screening of a Chemical Library
- (2013) Alexandre Ceccaldi et al. ACS Chemical Biology
- 5-Aza-2′-Deoxycytidine Enhances Maspin Expression and Inhibits Proliferation, Migration, and Invasion of the Bladder Cancer T24 Cell Line
- (2013) Huihui Zhang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Conceptual links between DNA methylation reprogramming in the early embryo and primordial germ cells
- (2013) Stefanie Seisenberger et al. CURRENT OPINION IN CELL BIOLOGY
- Usp18 deficient mammary epithelial cells create an antitumour environment driven by hypersensitivity to IFN-λ and elevated secretion of Cxcl10
- (2013) Christoph Burkart et al. EMBO Molecular Medicine
- Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin
- (2013) Maria Antonietta Sabatino et al. Epigenetics
- EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer
- (2013) Axel Heidenreich et al. EUROPEAN UROLOGY
- Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: Role of epigenetic mechanisms
- (2013) Albert Hagelgans et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β-catenin signal pathway in a renal cell carcinoma cell line
- (2013) Ece Konac et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Combination of low dose of genistein and daidzein has synergistic preventive effects on isogenic human prostate cancer cells when compared with individual soy isoflavone
- (2013) Xin Dong et al. FOOD CHEMISTRY
- Metabolism, mechanism of action and sensitivity profile of fluorocyclopentenylcytosine (RX-3117; TV-1360)
- (2013) Godefridus J. Peters et al. INVESTIGATIONAL NEW DRUGS
- Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells
- (2013) Soumik Agarwal et al. Molecular Cancer
- Integrated molecular analysis of clear-cell renal cell carcinoma
- (2013) Yusuke Sato et al. NATURE GENETICS
- The future of epigenetic therapy in solid tumours—lessons from the past
- (2013) Nilofer Azad et al. Nature Reviews Clinical Oncology
- Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines
- (2013) BARBORA FIALOVA et al. ONCOLOGY REPORTS
- Manipulating the epigenome for the treatment of urological malignancies
- (2013) Colm J. O'Rourke et al. PHARMACOLOGY & THERAPEUTICS
- Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer
- (2013) M T Schweizer et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma
- (2013) Christopher J Ricketts et al. Clinical Epigenetics
- Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells
- (2012) Hsing-Chen Tsai et al. CANCER CELL
- Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide
- (2012) Sandra Coral et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MG98, a Second-Generation DNMT1 Inhibitor, in the Treatment of Advanced Renal Cell Carcinoma
- (2012) Robert J. Amato et al. CANCER INVESTIGATION
- Epidemiology and Risk Factors of Urothelial Bladder Cancer
- (2012) Maximilian Burger et al. EUROPEAN UROLOGY
- Molecular mechanisms of cisplatin resistance in bladder cancer
- (2012) Ross M Drayton et al. Expert Review of Anticancer Therapy
- Gemcitabine reactivates epigenetically silenced genes and functions as a DNA methyltransferase inhibitor
- (2012) STEVEN G. GRAY et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Targeting the Unique Methylation Pattern of Androgen Receptor (AR) Promoter in Prostate Stem/Progenitor Cells with 5-Aza-2′-deoxycytidine (5-AZA) Leads to Suppressed Prostate Tumorigenesis
- (2012) Jing Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fluorocyclopentenyl-cytosine with Broad Spectrum and Potent Antitumor Activity
- (2012) Won Jun Choi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of Differentially Expressed Proteins in Curcumin-Treated Prostate Cancer Cell Lines
- (2012) Marie-Hélène Teiten et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation
- (2012) Bijesh K. Biswal et al. PLoS One
- DNMT1: An emerging target in the treatment of invasive urinary bladder cancer
- (2012) Deepika Dhawan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Epigenetic CpG Demethylation of the Promoter and Reactivation of the Expression of Neurog1 by Curcumin in Prostate LNCaP Cells
- (2011) Limin Shu et al. AAPS Journal
- Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation
- (2011) Tin Oo Khor et al. BIOCHEMICAL PHARMACOLOGY
- Role of epigenetics in developmental biology and transgenerational inheritance
- (2011) Michael K. Skinner BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
- Epigenetic biomarkers in urological tumors: A systematic review
- (2011) Carmen Jerónimo et al. CANCER LETTERS
- Epigenetic reprogramming in mouse pre-implantation development and primordial germ cells
- (2011) M. Saitou et al. DEVELOPMENT
- New nucleoside analogs for patients with hematological malignancies
- (2011) Tadeusz Robak EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Treatment of patients with relapsed and/or cisplatin-refractory metastatic germ cell tumours: an update
- (2011) D. Koychev et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- A demethylating agent enhances chemosensitivity to vinblastine in a xenograft model of renal cell carcinoma
- (2011) Hiroki Iwata INTERNATIONAL JOURNAL OF ONCOLOGY
- Subcutaneous 5-Azacitidine Treatment of Naturally Occurring Canine Urothelial Carcinoma: A Novel Epigenetic Approach to Human Urothelial Carcinoma Drug Development
- (2011) Noah M. Hahn et al. JOURNAL OF UROLOGY
- Methylation profile of DNA repetitive elements in human testicular germ cell tumor
- (2011) Hiroshi Ushida et al. MOLECULAR CARCINOGENESIS
- GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2′-Deoxycytidine Efficacy in Human Prostate Cancer Cells
- (2011) Karen Chiam et al. PLoS One
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Adaptation of Rhizobium leguminosarum to pea, alfalfa and sugar beet rhizospheres investigated by comparative transcriptomics
- (2011) Vinoy K Ramachandran et al. GENOME BIOLOGY
- Detailed analysis of expression and promoter methylation status of apoptosis-related genes in prostate cancer
- (2010) João R. Carvalho et al. APOPTOSIS
- Up-regulation of connexin 32 gene by 5-aza-2′-deoxycytidine enhances vinblastine-induced cytotoxicity in human renal carcinoma cells via the activation of JNK signalling
- (2010) Y. Takano et al. BIOCHEMICAL PHARMACOLOGY
- Unique DNA Methylation Patterns Distinguish Noninvasive and Invasive Urothelial Cancers and Establish an Epigenetic Field Defect in Premalignant Tissue
- (2010) E. M. Wolff et al. CANCER RESEARCH
- Structure and Function of Mammalian DNA Methyltransferases
- (2010) Renata Zofia Jurkowska et al. CHEMBIOCHEM
- Three Epigenetic Biomarkers, GDF15, TMEFF2, and VIM, Accurately Predict Bladder Cancer from DNA-Based Analyses of Urine Samples
- (2010) V. L. Costa et al. CLINICAL CANCER RESEARCH
- Implications of LINE1 Methylation for Bladder Cancer Risk in Women
- (2010) C. S. Wilhelm et al. CLINICAL CANCER RESEARCH
- Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene
- (2010) Hagit Schayek et al. EXPERIMENTAL CELL RESEARCH
- Green tea: A promising anticancer agent for renal cell carcinoma
- (2010) Márcia Carvalho et al. FOOD CHEMISTRY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance
- (2010) Hendrik Wermann et al. JOURNAL OF PATHOLOGY
- Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy
- (2010) B. Brueckner et al. MOLECULAR CANCER THERAPEUTICS
- Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells
- (2010) D. Kuck et al. MOLECULAR CANCER THERAPEUTICS
- S110, a 5-Aza-2'-Deoxycytidine-Containing Dinucleotide, Is an Effective DNA Methylation Inhibitor In vivo and Can Reduce Tumor Growth
- (2010) J. C. Chuang et al. MOLECULAR CANCER THERAPEUTICS
- Epigenetic modifications as therapeutic targets
- (2010) Theresa K Kelly et al. NATURE BIOTECHNOLOGY
- Epigenetic modifications in pluripotent and differentiated cells
- (2010) Alexander Meissner NATURE BIOTECHNOLOGY
- Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity
- (2010) Marcel W. Coolen et al. NATURE CELL BIOLOGY
- Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma
- (2010) M R Morris et al. ONCOGENE
- Mechanistic Insights on the Inhibition of C5 DNA Methyltransferases by Zebularine
- (2010) Christine Champion et al. PLoS One
- Gemcitabine Functions Epigenetically by Inhibiting Repair Mediated DNA Demethylation
- (2010) Andrea Schäfer et al. PLoS One
- 5-azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors
- (2010) Giovanni Luca Gravina et al. PROSTATE
- Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth
- (2010) Jianqing Lin et al. PROSTATE
- Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
- (2010) Mark R Morris et al. Genome Medicine
- Curcumin―The Paradigm of a Multi-Target Natural Compound with Applications in Cancer Prevention and Treatment
- (2010) Marie-Hélène Teiten et al. Toxins
- Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer
- (2009) Shahana Majid et al. CANCER
- Synergy of 5-aza-2′-deoxycytidine (DAC) and paclitaxel in both androgen-dependent and -independent prostate cancer cell lines
- (2009) Donghao Shang et al. CANCER LETTERS
- A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation
- (2009) J. Datta et al. CANCER RESEARCH
- High DNA Methyltransferase 3B Expression Mediates 5-Aza-Deoxycytidine Hypersensitivity in Testicular Germ Cell Tumors
- (2009) M. J. Beyrouthy et al. CANCER RESEARCH
- Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
- (2009) J. W.F. Catto et al. CANCER RESEARCH
- BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer
- (2009) S. Majid et al. CARCINOGENESIS
- A Phase I Dose-Finding Study of 5-Azacytidine in Combination with Sodium Phenylbutyrate in Patients with Refractory Solid Tumors
- (2009) J. Lin et al. CLINICAL CANCER RESEARCH
- Decitabine Effect on Tumor Global DNA Methylation and Other Parameters in a Phase I Trial in Refractory Solid Tumors and Lymphomas
- (2009) D. J. Stewart et al. CLINICAL CANCER RESEARCH
- Targeting DNA Methylation
- (2009) J.-P. J. Issa et al. CLINICAL CANCER RESEARCH
- Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors
- (2009) R. Plummer et al. CLINICAL CANCER RESEARCH
- Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
- (2009) Claudio Festuccia et al. ENDOCRINE-RELATED CANCER
- 2009 update on the classification of renal epithelial tumors in adults
- (2009) Antonio Lopez-Beltran et al. INTERNATIONAL JOURNAL OF UROLOGY
- Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma
- (2009) Barbara Seliger et al. Journal of Translational Medicine
- Bladder cancer
- (2009) Donald S Kaufman et al. LANCET
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- New Developments in the Medical Management of Prostate Cancer
- (2009) Manish Kohli et al. MAYO CLINIC PROCEEDINGS
- Azacitidine favorably modulates PSA kinetics correlating with plasma DNA LINE-1 hypomethylation in men with chemonaïve castration-resistant prostate cancer
- (2009) Guru Sonpavde et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma
- (2009) Naomi Walsh et al. BMC Urology
- Curcumin is a potent DNA hypomethylation agent
- (2008) Zhongfa Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Proteins that bind methylated DNA and human cancer: reading the wrong words
- (2008) L Lopez-Serra et al. BRITISH JOURNAL OF CANCER
- Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression
- (2008) Yinhong Song et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- DNA Hypomethylation Arises Later in Prostate Cancer Progression than CpG Island Hypermethylation and Contributes to Metastatic Tumor Heterogeneity
- (2008) Srinivasan Yegnasubramanian et al. CANCER RESEARCH
- Curcumin: From ancient medicine to current clinical trials
- (2008) H. Hatcher et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- A Phase I Biological Study of MG98, an Oligodeoxynucleotide Antisense to DNA Methyltransferase 1, in Patients with High-Risk Myelodysplasia and Acute Myeloid Leukemia
- (2008) R. B. Klisovic et al. CLINICAL CANCER RESEARCH
- Phase I Study of Epigenetic Modulation with 5-Azacytidine and Valproic Acid in Patients with Advanced Cancers
- (2008) F. Braiteh et al. CLINICAL CANCER RESEARCH
- Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead
- (2008) Antonello Mai et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
- (2008) Carlo Stresemann et al. INTERNATIONAL JOURNAL OF CANCER
- Retracted: Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells
- (2008) Nobuyuki Kikuno et al. INTERNATIONAL JOURNAL OF CANCER
- Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study
- (2008) Dominik R. Berthold et al. JOURNAL OF CLINICAL ONCOLOGY
- CpG Hypermethylation of the UCHL1 Gene Promoter is Associated With Pathogenesis and Poor Prognosis in Renal Cell Carcinoma
- (2008) Ichiro Kagara et al. JOURNAL OF UROLOGY
- Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors
- (2008) Georges J Netto et al. MODERN PATHOLOGY
- Origin of pluripotent germ cell tumours: The role of microenvironment during embryonic development
- (2008) David Møbjerg Kristensen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells
- (2008) Giovanni Luca Gravina et al. PROSTATE
- Demethylating Agent 5-Aza-2′-Deoxycytidine Enhances Susceptibility of Bladder Transitional Cell Carcinoma to Cisplatin
- (2008) Donghao Shang et al. UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started